Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention

doi:10.4330/wjc.v3.i11.367

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2640)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

301

HTML

2040

Figures (1-1)

152

Tables (1-4)

147

Sum=2640

Nov 26, 2011 (publication date) through May 14, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Cardiol. Nov 26, 2011; 3(11): 367-373
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367

Open in New Tab Full Size Figure Download Figure

Figure 1 Cumulative Kaplan-Meier curves of major adverse cardiac events-free survival according to clinically adequate dual antiplatelet therapy, adjusted for type of stent and Charlson comorbidity index. MACE: Major adverse cardiac events; DAT: Dual antiplatelet therapy.

Citation: Brugaletta S, Martin-Yuste V, Ferreira-González I, Cola C, Alvarez-Contreras L, Antonio MD, Garcia-Moll X, García-Picart J, Martí V, Balcells-Iranzo J, Sabaté M. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(11): 367-373
URL: https://www.wjgnet.com/1949-8462/full/v3/i11/367.htm
DOI: https://dx.doi.org/10.4330/wjc.v3.i11.367